BMO Hosts Third Annual Metabolic Health Summit on the Future of the GLP-1+ Market
Healthcare industry experts and leaders to convene
|
What: |
BMO Metabolic Health Summit 2026 |
|
|
Hosted & moderated by |
|
|
Head of Healthcare Research, |
|
|
|
|
Who: |
Industry leading BioPharma innovators, experts and investors |
|
|
|
|
When: |
|
|
|
|
|
Where: |
|
|
|
|
|
|
In-person only (no webcast) |
The BMO Metabolic Health Summit will deliver thought leadership and corporate management perspectives in a variety of formats such as fireside chats, expert panels and presentations, including:
- Discussions hosted by BMO analysts with leading life sciences companies, including Aardvark Therapeutics, Amgen, Ascletis Pharma, Biomea Fusion, Corbus Pharmaceuticals, Eli Lilly & Co., Novo Nordisk, Pfizer, and
Structure Therapeutics - Obesity 103 with
Katherine Saunders , MD, Obesity Physician & Co-Founder, FlyteHealth - A discussion on the state of Obesity Medicine in 2026 with Dr.
Louis J . Aronne, M.D.,Sanford I. Weill Professor ofMetabolic Research ,Weill Cornell Medical College - Panels on care delivery, emerging technologies, coverage and access ft. WeightWatchers, Metaphore Biotechnologies, Nuevocor Therapeutics, ProCare Rx,
Ro Health , Superluminal Medicines, andVirta Health - Insights from patients on GLP-1+ therapy
For more information or to request an interview with one of BMO's equity research analysts, please contact BMO Media Relations using the contact details below. Note: There may be restrictions for media on access to some presentations.
Event Resources: Agenda, Participating Companies
About BMO Financial Group
View original content:https://www.prnewswire.com/news-releases/bmo-hosts-third-annual-metabolic-health-summit-on-the-future-of-the-glp-1-market-302708732.html
SOURCE